Five things to know:
1. Teladoc posted $130.3 million in revenue, a 38 percent increase from $94.6 million during the second quarter of 2018.
2. For the first half of 2019, Teladoc reported $258.8 million in revenue, up 41 percent from $184.2 million during the same period last year.
3. Subscription access fees attributed to most of the telehealth company’s revenue at $111.2 million, up 40.5 percent from $79.8 million from the second quarter of 2018.
4. Teladoc reported a $29.3 million net loss for the second quarter of 2019, a 16 percent increase from $25.1 million during the same period last year.
5. For the third quarter of 2019, Teladoc anticipates its total revenue between $135 million and $138 million.
More articles on telehealth:
How telemedicine has become the new ‘home visit’ for Children’s National genetics patients
Teladoc names new COO: 4 things to know
Ohio payers now required to cover telemedicine visits
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
